|
28646.01.01
|
FIRAZYR INJ.SOL 30MG/3ML BTx 1PF.SYRx 3ML+1 βελόνα βελόνα
|
|
1.289,77 € |
1.434,48 € |
1.585,18 € |
Shire Pharmaceuticals Ireland Ltd
|
|
26735.02.03
|
FOSRENOL CHW.TAB 500MG/TAB BT x 90 HDPE CONTAINER HDPE CONTAINER
|
|
103,60 € |
119,08 € |
146,42 € |
Shire Pharmaceuticals Ireland Ltd
|
|
26735.03.05
|
FOSRENOL CHW.TAB 750MG/TAB BT x 90 HDPE CONTAINER HDPE CONTAINER
|
|
150,39 € |
172,86 € |
208,88 € |
Shire Pharmaceuticals Ireland Ltd
|
|
27162.01.01
|
MEZAVANT GR.PR.R.TA 1200MG/TAB BT x 60 (BLIST. POLYAMIDE/AL/PVC) (BLIST. POLYAMIDE/AL/PVC)
|
|
41,17 € |
47,32 € |
65,21 € |
Shire Pharmaceuticals Ireland Ltd
|
|
31684.04.01
|
NATPAR PS.INJ.SOL 100MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου)
|
|
5.114,44 € |
5.688,31 € |
6.150,20 € |
Shire Pharmaceuticals Ireland Ltd
|
|
31684.01.01
|
NATPAR PS.INJ.SOL 25MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου)
|
|
5.114,44 € |
5.688,31 € |
6.150,20 € |
Shire Pharmaceuticals Ireland Ltd
|
|
31684.02.01
|
NATPAR PS.INJ.SOL 50MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου)
|
|
5.114,44 € |
5.688,31 € |
6.150,20 € |
Shire Pharmaceuticals Ireland Ltd
|
|
31684.03.01
|
NATPAR PS.INJ.SOL 75MCG/δόση 2 φυσίγγια -γυάλινο (διπλού θαλάμου)
|
|
5.114,44 € |
5.688,31 € |
6.150,20 € |
Shire Pharmaceuticals Ireland Ltd
|
|
29486.01.01
|
RESOLOR F.C.TAB 1MG/TAB BTx28x1 σε BLISTERS ALU/ALU ALU/ALU
|
|
36,18 € |
41,78 € |
59,79 € |
Shire Pharmaceuticals Ireland Ltd
|
|
29486.02.01
|
RESOLOR F.C.TAB 2MG/TAB BTx28x1 σε BLISTERS ALU/ALU ALU/ALU
|
|
55,38 € |
63,96 € |
91,53 € |
Shire Pharmaceuticals Ireland Ltd
|
|
30409.01.01
|
REVESTIVE PS.INJ.SOL 5MG/VIAL BTx28 VIALS+28 προγεμισμένες σύριγγες + 6 έμβολα
|
|
15.279,70 € |
16.994,56 € |
18.374,52 € |
Shire Pharmaceuticals Ireland Ltd
|
|
29737.02.01
|
VPRIV PD.SOL.INF 400U/VIAL 1 VIALx 400U
|
|
1.196,84 € |
1.331,13 € |
1.470,96 € |
Shire Pharmaceuticals Ireland Ltd
|
|
26736.01.01
|
XAGRID CAPS 0,5MG/CAP BTx1VIALx100
|
|
274,36 € |
305,15 € |
355,81 € |
Shire Pharmaceuticals Ireland Ltd
|
